Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Import Task Force Seeks Information On FDA-Approved Drugs Sold Abroad

Executive Summary

FDA is working to determine the number of drugs sold abroad that are manufactured and labeled according to U.S. standards, former FDA Commissioner McClellan told a meeting of the HHS importation task force

You may also be interested in...



Rx Importation Would Lead To Two Drug Classes – FDA Chief Counsel Troy

A legalized drug importation system would likely lead to the emergence of two classes of drugs, FDA Chief Counsel Dan Troy predicted

Rx Importation Would Lead To Two Drug Classes – FDA Chief Counsel Troy

A legalized drug importation system would likely lead to the emergence of two classes of drugs, FDA Chief Counsel Dan Troy predicted

FDA Website Should List Internet Pharmacies Approved To Import, AARP Says

FDA should use its website and a toll-free hotline to direct consumers to international pharmacies the agency has determined to be "safe," AARP says

Related Content

UsernamePublicRestriction

Register

OM004674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel